Cognex Corporation (NASDAQ: CGNX) — 2012 Form 10-K
Business context and reporting period. Machine-vision products and services provider serving manufacturing and logistics applications. Fiscal year ended December 31, 2012; the filing also reports fourth-quarter results. MVSD accounted for about 84% of annual revenue; SISD focuses on continuous-material surface inspection.
Financial performance and position
Dollar amounts below are in millions, except per-share data and percentages.
| Metric | FY 2012 | FY 2011 |
|---|---|---|
| Revenue | $324.3 | $321.9 |
| Gross profit / gross margin | $244.8 / 75.5% | $244.0 / 75.8% |
| Operating income / margin | $83.4 / 25.7% | $85.4 / 26.5% |
| Net income / diluted EPS | $68.1 / $1.56 | $69.9 / $1.63 |
| Cash from operations | $101.1 | $86.3 |
| Capital expenditures | $9.9 | $7.8 |
- Fourth-quarter 2012 revenue was $82.2 million, operating income $20.5 million, and net income $16.2 million; diluted EPS was $0.37.
- Annual product revenue declined 1% to $295.6 million, while service revenue rose 17% to $28.7 million. Product gross margin held at 78%; service gross margin improved to 51% from 46%.
- Factory automation revenue increased 4% reported (7% excluding currency effects); surface inspection rose 5%; semiconductor and electronics capital-equipment revenue fell 24%.
- At year-end, cash and investments totaled $388.5 million, working capital was $189.5 million, total assets were $627.6 million, and shareholders’ equity was $572.3 million. Cognex reported no long-term debt and no off-balance-sheet arrangements.
- Operating cash flow increased to $101.1 million. Cash dividends paid were $66.2 million, including accelerated and special dividends.
Changes, outlook, risks, and unusual items
- Revenue rose just 1% year over year as growth in factory automation and surface inspection was largely offset by the cyclical semiconductor/electronics decline. Operating income and net income decreased despite higher operating cash flow.
- Management identified China and ID products as expected growth opportunities in 2013 and expected to continue significant R&D investment, targeting R&D spending of 10%–15% of revenue. The filing provides no specific consolidated revenue or earnings guidance.
- Management cited slower consumer-electronics demand in China late in 2012 and limited visibility in the cyclical semiconductor/electronics market. Other key risks include global manufacturing spending, automotive exposure, international operations and currency movements, supplier concentration, product transitions, competition, and execution in logistics automation.
- Dividend payments included $1.11 per share accelerated in Q4 2012: $0.11 ordinarily expected in early 2013 and a $1.00 special dividend intended to replace expected dividends for 2013–2014. Future dividends remain at the Board’s discretion.
- The company recorded $0.88 million of foreign-currency losses; a hedge related to converting its Euro investment portfolio generated a $0.50 million loss. A 2013 tax-law change was expected to reduce Q1 2013 tax expense by approximately $0.56 million.
- Patent litigation against MvTec and related parties remained ongoing on appeal after an adverse ITC determination; the company said an adverse outcome could materially affect financial position, liquidity, results, or indemnification obligations. No significant contingency accrual was reported.
- Grant Thornton gave unqualified opinions on the financial statements and internal control over financial reporting. No impairment charges were recorded in 2012.
Important facts for investors to verify
- Whether factory-automation and ID-product growth can offset continuing weakness or cyclicality in semiconductor/electronics customers.
- Whether reported margin and earnings trends improve, particularly given lower product revenue and increased strategic headcount and investment.
- Liquidity composition and investment risks, including the $3.7 million carrying value of the venture-capital partnership interest (estimated fair value $6.9 million) and potential impairment exposure.
- Developments and potential financial exposure in the pending patent appeal and tax examinations or reserves.
- Dividend policy and capital allocation after the unusually large 2012 accelerated and special payments; confirm that future distributions are not assured.